Icon

SPIRIVA RESPIMAT (nda021936)- (EQ 0.0025MG BASE/INH,EQ 0.00125MG BASE/INH)

TIOTROPIUM BROMIDE BOEHRINGER INGELHEIM
EQ 0.0025MG BASE/INH,EQ 0.00125MG BASE/INH
Yes No
2031-Apr-16 Expired
None 2017-Sep-24
None No
SPIRIVA RESPIMAT is an anticholinergic indicated for:  The long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations  The long-term, once-daily, maintenance treatment of asthma in patients 6 years of age and older
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 0.0025MG BASE/INH ** ** Up - -
EQ 0.00125MG BASE/INH ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.